Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · IEX Real-Time Price · USD
3.12
+0.12 (4.00%)
At close: Dec 29, 2023, 4:00 PM
3.18
+0.06 (1.92%)
After-hours: Dec 29, 2023, 4:00 PM EST
Akari Therapeutics, Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for AKTX stock.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for AKTX.
Recommendation Trends
| Rating | Jul '22 | Aug '22 | Sep '22 | Oct '22 | Nov '22 | Dec '22 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 1 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +861.54% | Dec 5, 2022 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $80 | Strong Buy | Initiates | $80 | +2,464.10% | Nov 1, 2022 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Mar 29, 2018 |
| B. Riley Securities | B. Riley Securities | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Feb 8, 2018 |
| William Blair | William Blair | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Sep 22, 2017 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.08
EPS Next Year
-3.47
from -4.08
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | n/a | n/a | 4.4M |
| Avg | n/a | n/a | 4.3M |
| Low | n/a | n/a | 4.1M |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | -4.20 | -3.57 | -3.78 |
| Avg | -4.08 | -3.47 | -3.67 |
| Low | -3.92 | -3.33 | -3.53 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.